Table 1.
Clinical data and hormone levels of acromegaly patients.
| Whole group (n = 61) | Male patients (n = 34) | Female patients (n = 27) | |
|---|---|---|---|
| Age (year) | 43.2 ± 13.3 | 40.6 ± 12.2 | 46.4 ± 14.0 |
| Body mass index (kg/m2) | 26.1 ± 3.8 | 27.5 ± 4.1 | 24.4 ± 2.6∗ |
| Disease duration (month) | 78.5 ± 57.0 | 82.4 ± 58.6 | 73.6 ± 55.7 |
| GH (ng/ml) | 36.3 ± 43.7 | 35.7 ± 44.0 | 42.6 ± 57.8 |
| GH nadir (ng/ml) | 28.2 ± 41.4 | 26.1 ± 35.3 | 30.8 ± 48.5 |
| IGF-1 (ng/ml) | 896.4 ± 253.9 | 978.9 ± 234.1 | 792.6 ± 243.0∗ |
| Heart rate (beats/min) | 78.1 ± 6.1 | 78.0 ± 6.7 | 78.2 ± 5.3 |
| Systolic blood pressure (mmHg) | 122.6 ± 11.6 | 121.4 ± 10.5 | 124.2 ± 12.9 |
| Diastolic blood pressure (mmHg) | 77.3 ± 8.9 | 78.8 ± 9.6 | 75.5 ± 7.8 |
| Arterial hypertension (yes/no, %) | 11/50, 18.0 | 9/25, 26.5 | 2/25, 7.4 |
| Hyperlipemia (yes/no, %) | 8/53, 13.1 | 5/29, 8.2 | 3/24, 4.9 |
| Diabetes mellitus (yes/no, %) | 8/53, 13.1 | 4/30, 6.6 | 4/23, 6.6 |
| Smoking habit (yes/no, %) | 12/49, 19.7 | 11/23, 32.4 | 1/26, 3.7∗ |
GH, growth hormone; IGF-1, insulin-like growth factor 1. Values are presented as frequencies (%) and the mean ± standard deviation. ∗It means the difference between male and female patients is significant (p < 0.05).